corticotropin releasing factor receptor-2 inhibitors (Clayton)

N/A

Report date: 2025/01/26 17:21:09
NME

Base Information

Drug Namecorticotropin releasing factor receptor-2 inhibitors (Clayton)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCorticotropin-releasing factor receptor 2 antagonists
TargetsCorticotropin-releasing factor receptor 2
Therapy Area/IndicationsMetabolic SyndromeDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesClayton Foundation For Research
China Registration ClassN/A

Develop Information

Active CompaniesClayton Foundation For Research
Inactive CompaniesN/A
Active IndicationsMetabolic SyndromeDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A